SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 26 filers reported holding SINOVAC BIOTECH LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 13,787 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q1 2021 | $55,000 | 0.0% | 13,787 | -38.4% | 0.00% | – |
| Q4 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q1 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q4 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2019 | $55,000 | -61.8% | 22,374 | 0.0% | 0.00% | – |
| Q1 2019 | $144,000 | -7.1% | 22,374 | 0.0% | 0.00% | – |
| Q4 2018 | $155,000 | -8.8% | 22,374 | 0.0% | 0.00% | – |
| Q3 2018 | $170,000 | – | 22,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |